Mergers & Acquisitions


Corporate transactions comprise a foundational practice area of DaHui, and our unparalleled competence – particularly in cross-border M&A – has gone hand in hand with our growth and success. We thus remain committed to bringing our unique commercial insight, technical mastery of the law, and global perspective to bear in advising our clients on their most complex and challenging mergers, acquisitions, joint ventures, spin-offs, SPAC deals, and other corporate transactions.

With the Chinese economy’s incredible growth and integration into the world economy, M&A has become an efficient way to quickly establish a company’s presence in target markets or to dispose of assets in order to focus on core businesses. M&A, particularly as it relates to the Chinese market, has increasingly attracted the attention of foreign enterprises seeking to enter the Chinese market, as well as Chinese domestic enterprises aiming to expand their businesses to global markets. We are among the PRC firms with the highest ratio of cross-border to domestic M&A deals, and we most often serve as lead or sole counsel for all the deals in which we are involved.

Our services in this area include:

  • Comprehensive buy-side and sell-side legal assistance and deal management
  • Market entry acquisitions and market-exit sales
  • Strategic mergers
  • China aspects of global M&A
  • Joint ventures and alliances, including China’s most innovative structuring options (e.g., the “JV 3.0” model)
  • Asset purchases and sales
  • Hybrid “equity”/“asset” deals unique in the China market
  • SPAC business combinations
  • Spin-offs, restructurings, and redomicile mergers
  • Unique cross-border VIE-related M&A for restricted industries

Relevant Experience

Apyx Medical

Represented Apyx Medical (f.k.a. Bovie Medical), an advanced energy technology company listed on NASDAQ (APYX), in its establishment of a joint venture with a local partner to manufacture, research, develop and sell electrosurgery generators in China.


Assisted CBS with multiple stages of its entrance, expansion and re-alignment in the China market, including the spin-off sale of one of its subsidiaries holding a rare, key license (for publication of a/v programs) to Pinduoduo, the third-largest e-commerce business in China.

China International Capital Corporation

Served as lead counsel to China International Capital Corporation Limited (CICC) on its acquisition of Stenders, the Latvian cosmetics producer and seller serving 27 countries - the signing of the deal was witnessed by Premier Li Keqiang.


Advised Evernote to spin-off the local entity Yinxiang Biji, including the corporate, investment and management incentive structuring (utilizing an innovative "JV 3.0" framework), as well as operating permit and other regulatory requirements in China's highly regulated Internet industry, to ensure flexible yet synergistic growth of the local and global businesses.

Genesis Capital

Advised Genesis Capital on a USD 70 million financing of Tantan, China's top dating app, and in its subsequent sale to Momo, the Chinese location-based social networking app.

Related News & Insights

Feb 17, 2024

DaHui Again Ranked among Top PRC Law Firms in Chambers’ Global Guide
Read Article

Jan 30, 2024

DaHui Pens Insights on Tech M&A in China for Chambers Global Practice Guide
Read Article

Nov 17, 2023

DaHui Recognized Among Top PRC Firms by The Legal 500 in Nineteen Rankings
Read Article

© DaHui Lawyers